Richardson, has published promising findings from the past seven years of research into a new approach for the treatment of ...

FDA approved AstraZeneca's Imfinzi regimen for muscle-invasive bladder cancer, while the EU backed Calquence combo for untreated mantle cell lymphoma.

The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).

In high doses, ivermectin can be toxic and cause central nervous system problems like blurred vision, confusion and seizures, ...

Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

A new study from Cornell University has strengthened the case for using a specific group of molecules—known as microRNAs—as ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

Jocelyn and Kristofer Carella-Erickson detail their traumatic back-to-back cancer experiences with PEOPLE — and say their ...

Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

In an advance for treating male infertility, researchers transplanted a patient with his own sperm-forming stem cells that ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...